Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jun
11
2015
D.C. Circuit Affirms: FTC Can Change HSR Rules Targeted at Pharmaceutical Patents Mintz
Jun
10
2015
Nut Imposters: Increased Number of EU and US Recalls Relating to Nut Products and Undeclared Allergens, Despite Overall Reduction in EU Squire Patton Boggs (US) LLP
Jun
10
2015
Michigan Department of Agriculture and Rural Development Workgroup Recommends Legislation to Support Urban Livestock Operations Varnum LLP
Jun
10
2015
NDRC Issued Opinions and Notice on Drug Price Reform: National Development and Reform Commission Sheppard, Mullin, Richter & Hampton LLP
Jun
9
2015
Positive Workplace Drug Test Results On The Rise For Second Straight Year, Study Finds Jackson Lewis P.C.
Jun
9
2015
FDA Finally Releases Initial Framework for Food Importation “VQIP”: Voluntary Qualified Importer Program Mintz
Jun
9
2015
State Action May Block Big Savings on Biosimilars Mintz
Jun
9
2015
Zofran Studies Link Medication to Serious Health Risks Stark & Stark
Jun
9
2015
Federal Circuit Finds Nunc Pro Tunc Agreement Does Not Confer Standing Foley & Lardner LLP
Jun
9
2015
FDA Issues Draft Guidance on Voluntary Qualified Importer Program Under the Food Safety Modernization Act Barnes & Thornburg LLP
Jun
8
2015
Voluntary Qualified Importer Program Draft Guidance: Incentivizing Food Import Safety Morgan, Lewis & Bockius LLP
Jun
7
2015
Federal Circuit Hears Oral Arguments in Litigation involving the First U.S. Biosimilar Product Michael Best & Friedrich LLP
Jun
7
2015
Brazil’s New Biodiversity Law Michael Best & Friedrich LLP
Jun
6
2015
Scrutiny of Nail Salon Chemicals Raises Mass Tort Risk ArentFox Schiff LLP
Jun
5
2015
SAMHSA Seeks Comments on Hair Testing For Drugs - Substance Abuse and Mental Health Services Administration Jackson Lewis P.C.
Jun
5
2015
USDA Proposed Rule Limits Payments to Non-Farmers Varnum LLP
Jun
4
2015
Catch of the Day: Tuna Fish Brand StarKist Swims into a Sea of Trouble After Agreeing to Settle Claims Against It Proskauer Rose LLP
Jun
4
2015
The Federal Circuit’s First Foray into the BPCIA: “A Pulitzer Prize for Complexity”? Mintz
Jun
4
2015
Act II: Oral Argument in Amgen v. Sandoz is heard at the Court of Appeals for the Federal Circuit Sterne, Kessler, Goldstein & Fox P.L.L.C.
Jun
4
2015
New USDA Study Says COOL not Beneficial to American Consumers - Country-of-Origin Labeling Varnum LLP
Jun
4
2015
Second Circuit Holds a Hard Switch Between Drugs Is an Unlawful Product Hop Under Section 2 Mintz
Jun
4
2015
Federal Circuit Hears Oral Arguments in Neupogen Biosimilar Case Foley & Lardner LLP
Jun
3
2015
Multiple DWI Convictions Don’t Create A “Record of” Alcoholism Under ADA; Driving Restrictions Don’t Support “Regarded As” Claim Jackson Lewis P.C.
Jun
2
2015
Big Win for Anti-GMO Groups as Oregon Federal Judge Upholds Jackson County GMO Ban Mintz
Jun
2
2015
FTC’s $1.2 Billion Disgorgement Settlement With Cephalon: Heightened Scrutiny of Hatch-Waxman Settlements Foley & Lardner LLP
Jun
2
2015
New Regulations in the Administration of Buprenorphine, Part One McBrayer, McGinnis, Leslie and Kirkland, PLLC
Jun
2
2015
Cosmetic Safety Legislation Introduced, Again Beveridge & Diamond PC
Jun
2
2015
Another Sequenom Patent Appeal Heads To The Federal Circuit Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins